Metabolic Phenotype and Adipose Tissue Inflammation in Patients with Chronic Obstructive Pulmonary Disease

Table 2

Characteristics of the respective components of the metabolic syndrome in COPD patients.

	Group				P value
	Cachectic	Normal weight	Overweight	Obese
Central obesity*	0 (0)	6 (50.0)	12 (100)	11 (100)	<.001
Raised blood pressure*	2 (22.2)	4 (12.5)	8 (66.6)	11 (100)	.001
Raised triglycerides*	0 (0)	1 (8.3)	1 (8.3)	7 (63.6)	<.001
Reduced HDL cholesterol*	0 (0)	1 (8.3)	0 (0)	3 (27.3)	.089
Raised fasting plasma glucose*	0 (0)	5 (41.6)	4 (33.3)	8 (72.7)	.010

Values are given as No (%).
*Central obesity: waist circumference > 94 cm (men) or >80 cm (women); raised blood pressure: systolic BP ≥ 130 mm Hg or diastolic BP ≥ 85 mm Hg, or treatment of previously diagnosed hypertension; raised triglycerides: >150 mg·dL⁻¹ or specific treatment; reduced HDL cholesterol < 40 mg·dL⁻¹ (men) or <50 mg·dL⁻¹ (women), or specific treatment; raised fasting plasma glucose > 100 mg·dL⁻¹ or specific treatment.
HDL: high density lipoprotein; BMI: body mass index.